Jelena G. Najdanović

Jelena G. Najdanović

Auto-generated profile, based on publicly available information

Jelena G. Najdanović

Department of Biology and Human Genetics, Faculty of Medicine, University of Niš, Niš, Serbia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
VCVladimir J. Cvetković
Vladimir J. Cvetković
JNJelena G. Najdanović
Jelena G. Najdanović
MVMarija Đ. Vukelić-Nikolić
Marija Đ. Vukelić-Nikolić
Sanja StojanovićSanja Stojanović
Sanja Stojanović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman

1 January 2014 in Folia Biologica
Verified
Journal Article
Open access
PDF file
ISI. Ž. Stojanović
I. Ž. Stojanović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
OJO. Jovanović
O. Jovanović
GPG. Petrović
G. Petrović
JNJ. Najdanović
J. Najdanović
AŠAndrija Šmelcerović
Andrija Šmelcerović
The anti-proliferative activitiy of Hypogymnia physodes methanol extracts (ME) and its main constituents, physodalic acid (P1), physodic acid (P2), and 3-hydroxy physodic acid (P3), was tested on human cancer HeLa cell lines. Three lichen depsidones, P1, P2 and P3, were isolated from H. physodes ME using column chromatography and their structures were determined by UV, ESI TOF MS, 1 H and 13 C NMR. The content of P1, P2 and P3 in ME was determined using reversed-phase highperformance liquid chromatography with photodiode array detection. P1–3 represented even 70 % of the studied extract. The HeLa cells were incubated during 24 and 72 h in the presence of ME and depsidones P1, P2 and P3, at concentrations of 10–1000 μg/ml. Compounds P2 and P3 showed higher activity than compound P1. Half maximal inhibitory concentrations (IC 50 , μg/ml) of P1, P2, P3 and ME for 24-h incubation were 964, 171, 97 and 254 μg/ml, respectively, while for 72-h incubation they were 283, 66, 63 and 68 μg/ml. As far as we know, this is the first report on the effect of H. physodes ME and their depsidones on HeLa cells.

1 October 2016 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
VCVladimir J. Cvetković
Vladimir J. Cvetković
JNJelena G. Najdanović
Jelena G. Najdanović
Sanja StojanovićSanja Stojanović
Sanja Stojanović
MVMarija Đ. Vukelić-Nikolić
Marija Đ. Vukelić-Nikolić
DPDragan Petrović
Dragan Petrović

1 January 2015 in Archives of Biological Sciences
Verified
Journal Article
Open access
PDF file
JŽJelena Živković
Jelena Živković
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
MVMarija Đ. Vukelić
Marija Đ. Vukelić
Sanja StojanovićSanja Stojanović
Sanja Stojanović
MAMilena V. Aleksić
Milena V. Aleksić
JNJelena G. Najdanović
Jelena G. Najdanović
We analyzed the influence of inflammatory macrophages on the osteogenic process in subcutaneous implants composed of mineral bone substitute. Thioglycollate-elicited peritoneal macrophages (TEPMs) were characterized as inflammatory. This was confirmed microscopically by the nitroblue tetrazolium (NBT) test and the production of tumor necrosis factor ? (TNF-?). The implants (M-type) were made of mineral bone substitute (Bio-Oss?) mixed with TEPMs and blood clot. Implants without macrophages served as the control (C-type). Subcutaneous implantation in the interscapular area was performed on BALB/c mice. Implants were extracted after 2 and 8 weeks. In M-type implants, phagocytosis and angiogenesis were more pronounced, and osteoblast-like cells aligned onto granules of implanted material and osteoid structures can be seen. The observed higher osteocalcin and lower osteopontin immunoexpression in M-type implants when compared to the control after 8 weeks suggest a more advanced osteogenic process. Our results indicate that the presence of inflammatory macrophages in the composition of an implant may have a beneficial effect on the osteogenic process.

30 June 2015 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
JNJelena G. Najdanović
Jelena G. Najdanović
VCVladimir J. Cvetković
Vladimir J. Cvetković
Sanja StojanovićSanja Stojanović
Sanja Stojanović
MVMarija Đ. Vukelić-Nikolić
Marija Đ. Vukelić-Nikolić
MSMilica N. Stanisavljević
Milica N. Stanisavljević
Stevo J. NajmanStevo J. Najman
Stevo J. Najman

15 August 2016 in Materials Research
Verified
Journal Article
Open access
PDF file
DMDijana Takić Miladinov
Dijana Takić Miladinov
Simonida Lj. TomicSimonida Lj. Tomic
Simonida Lj. Tomic
Sanja StojanovićSanja Stojanović
Sanja Stojanović
JNJelena Najdanović
Jelena Najdanović
JFJovanka Filipović
Jovanka Filipović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
In this study we prepared hydrogels based on 2-hydroxyethyl methacrylate (HEMA): PHEMA homopolymer and two terpolymers of HEMA, itaconic acid (IA) and two poly(alkylene glycol) (meth) acrylates (PAGM): poly(ethylene glycol)6 acrylate (P(HEMA/IA/PAGM1)) and poly(propylene glycol)5 methacrylate (P(HEMA/IA/PAGM2)). Hydrogels were synthesized by gamma-irradiated radical polymerization and subjected to swelling measurements and genotoxicity evaluation. Swelling studies confirmed that these hydrogels deserve consideration as biomaterials due to their ability to swell in phosphate buffer but maintaining physical integrity for a prolonged contact time after equilibrium state has been reached. Comet assay showed certain genotoxic effect following cell exposure to extracts of hydrogels, which was dependent on the concentration of extracts, chemical composition of hydrogels and the degree of crosslinking. The influence of concentration on genotoxicity was the most pronounced. The synthesis of these novel HEMA-based hydrogels should be optimized so as to reduce their toxicity and enable the use in clinical practice.